organization · Reporting owner
STONE STREET FUND 1995 LP
Disclosed activity across 1 company
Sign in to followReported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AAIPHARMA INCAAIIE · Entity 14033 | 10% owner | June 16, 2004 | June 18, 2004 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AAIPHARMA INC
Report date June 16, 2004 · Filed June 18, 2004
Jointly reported with GOLDMAN SACHS GROUP INC, GOLDMAN SACHS & CO. LLC, GS CAPITAL PARTNERS II L P, GS CAPITAL PARTNERS II OFFSHORE LP, GS CAPITAL PARTNERS II GERMANY CLP, BRIDGE STREET FUND 1995 LP, GS ADVISORS II LLC, GS ADVISORS LLC
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $4.12 · Expires 2014-06-16 | IndirectSee Footnote | 5,000 |
Reported balance
After 2004-06-16 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2004-06-16 · Grant · Acquired 5,000 · Balance 5,000 F5: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are immediately exercisable. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $17.98 · Expires 2013-11-20 | IndirectSee Footnote | 15,000 |
Reported balance
Holding disclosure · report date 2004-06-16 · row 3
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 3 · Balance 15,000 F6: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, w hich was November 20, 2003, and 33.4% on the third anniversary of the grant date. |
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $11.44 · Expires 2012-08-02 | IndirectSee Footnote | 15,000 |
Reported balance
Holding disclosure · report date 2004-06-16 · row 4
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 4 · Balance 15,000 F7: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, w hich was August 2, 2002, and 33.4% on the third anniversary of the grant date. |
| Common StockSEC Table I · non-derivative | IndirectSee Footnotes | 3,415,602 |
Reported balance
Holding disclosure · report date 2004-06-16 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 3,415,602 F1: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Adv isors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs) and The Goldman Sachs Group, Inc. ("GS Group", together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F2: Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly 355 shares of aaiPharma Inc. common stock, $0.001 par value per share ("Common Stock"). Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of its pecuniary interest therein. F3: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directl y and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F4: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. |
Filing footnotes · ownership attribution and instrument terms
F1: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Adv isors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs) and The Goldman Sachs Group, Inc. ("GS Group", together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate.
F2: Goldman Sachs beneficially owns directly and GS Group may be deemed to beneficially own indirectly 355 shares of aaiPharma Inc. common stock, $0.001 par value per share ("Common Stock"). Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of its pecuniary interest therein.
F3: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directl y and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge.
F4: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities.
F5: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are immediately exercisable.
F6: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, w hich was November 20, 2003, and 33.4% on the third anniversary of the grant date.
F7: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, w hich was August 2, 2002, and 33.4% on the third anniversary of the grant date.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 16, 2004 Filed Jun 18, 2004 22:27 UTC | AAIPHARMA INC AAIIE · Entity 14033 | GrantStock Option (right to buy) · Derivative | 5,000 | $0.00 Strike: $4.12 | $0.00 |
DisclosureSEC source: 0000769993-04-000397 · aaii4040616gsg_ex.xml · derivative · entry 2 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 LP · CIK 0000941168 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 5,000 Underlying: Common Stock · 5,000 shares Expires 2014-06-16 F5 · derivative.exercise_date: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are immediately exercisable. F5 · ownership.nature: These options were granted pursuant to aaiPharma Inc.'s 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of aaiPharma Inc. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is a direct and indirect wholly-owned subsidiary of GS Group. These options are immediately exercisable. Read SEC document |
| March 19, 2004 Filed Mar 26, 2004 23:43 UTC | AAIPHARMA INC AAII · Entity 14033 | OtherCommon Stock | 355 | $0.00 | $0.00 |
DisclosureSEC source: 0000895345-04-000217 · jl4-aaipharma_goldmanex.xml · nonDerivative · entry 1 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner STONE STREET FUND 1995 LP · CIK 0000941168 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET 1995 LLC · CIK 0001232096 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Disclosed balance after: 3,415,602 F1 · kind: As a result of an internal restructuring among subsidiaries of The Goldman Sachs Group, Inc. ("GS Group"), 355 shares of Common Stock that were previously held by affiliates of GS Group but were disaggregated from securities held by the investment partnerships specified below in footnote 2 are now held directly by Goldman, Sachs & Co. ("Goldman Sachs") and are aggregated with securities held by such investment partnerships. F2 · ownership.nature: This statement is being filed by GS Capital Partners II, L.P. ("GSCP"), GS Capital Partners II Offshore, L.P. ("GSCP II Offshore"), GS Capital Partners II (Germany) Civil Law Partnership ("GSCP II Germany"), Stone Street Fund 1995, L.P. ("1995 Stone") and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. ("Stone GP"), GS Advisors, L.L.C. ("GS Advisors"), GS Advisors II, L.L.C. ("GS Advisors II"), Goldman, Sachs & Co. oHG ("GS oHG"), Goldman Sachs and GS Group (together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F3 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein. F4 · ownership.nature: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F5 · ownership.nature: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. Read SEC document |
| November 20, 2003 Filed Nov 24, 2003 22:44 UTC | AAIPHARMA INC aaii · Entity 14033 | GrantStock Option (right to buy) · Derivative | 15,000 | Not disclosed Strike: $17.98 | Not disclosed |
DisclosureSEC source: 0000769993-03-000632 · aaii4031120gsg_ex.xml · derivative · entry 2 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 LP · CIK 0000941168 · 10% owner GOLDMAN SACHS & CO OHG · CIK 0001031766 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnote Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2013-11-20 F5 · price: These options were granted pursuant to the Company's 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of the Company. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, which was November 20, 2003 and 33.4% on the third anniversary of the grant date. F5 · derivative.exercise_date: These options were granted pursuant to the Company's 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of the Company. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, which was November 20, 2003 and 33.4% on the third anniversary of the grant date. F5 · ownership.nature: These options were granted pursuant to the Company's 2000 Stock Option Plan for Non-Employee Directors, to a managing director of Goldman Sachs in his capacity as a director of the Company. That director has an understanding with GS Group pursuant to which he holds the stock options for the benefit of GS Group. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. These options are exercisable as follows: 33.3% on the first and second anniversaries of the grant date, which was November 20, 2003 and 33.4% on the third anniversary of the grant date. Read SEC document |
| November 14, 2003 Filed Nov 17, 2003 23:47 UTC | AAIPHARMA INC aaii · Entity 14033 | PurchaseCommon Stock | 400 | $19.21 | $7,684.00 |
DisclosureSEC source: 0000769993-03-000626 · aaii4031113gsg_ex.xml · nonDerivative · entry 3 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 LP · CIK 0000941168 · 10% owner GOLDMAN SACHS & CO OHG · CIK 0001031766 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,415,247 F1 · ownership.nature: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Advisors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs), and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F2 · ownership.nature: The securities reported herein as purchased and sold were purchased and sold and were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to aaiPharma, Inc. (the "Company"). The Reporting Persons other than GS Group and Goldman Sachs disclaim beneficial ownership of the shares of Common Stock beneficially owned directly by Goldman Sachs. F3 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein. F4 · ownership.nature: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F5 · ownership.nature: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. Read SEC document |
| November 13, 2003 Filed Nov 17, 2003 23:47 UTC | AAIPHARMA INC aaii · Entity 14033 | SaleCommon Stock | 101 | $19.12 | $1,931.12 |
DisclosureSEC source: 0000769993-03-000626 · aaii4031113gsg_ex.xml · nonDerivative · entry 2 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 LP · CIK 0000941168 · 10% owner GOLDMAN SACHS & CO OHG · CIK 0001031766 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,414,847 F1 · ownership.nature: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Advisors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs), and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F2 · ownership.nature: The securities reported herein as purchased and sold were purchased and sold and were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to aaiPharma, Inc. (the "Company"). The Reporting Persons other than GS Group and Goldman Sachs disclaim beneficial ownership of the shares of Common Stock beneficially owned directly by Goldman Sachs. F3 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein. F4 · ownership.nature: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F5 · ownership.nature: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. Read SEC document |
| November 13, 2003 Filed Nov 17, 2003 23:47 UTC | AAIPHARMA INC aaii · Entity 14033 | SaleCommon Stock | 299 | $19.16 | $5,728.84 |
DisclosureSEC source: 0000769993-03-000626 · aaii4031113gsg_ex.xml · nonDerivative · entry 1 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 LP · CIK 0000941168 · 10% owner GOLDMAN SACHS & CO OHG · CIK 0001031766 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,414,948 F1 · ownership.nature: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Advisors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs), and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F2 · ownership.nature: The securities reported herein as purchased and sold were purchased and sold and were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to aaiPharma, Inc. (the "Company"). The Reporting Persons other than GS Group and Goldman Sachs disclaim beneficial ownership of the shares of Common Stock beneficially owned directly by Goldman Sachs. F3 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein. F4 · ownership.nature: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F5 · ownership.nature: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. Read SEC document |
| October 23, 2003 Filed Oct 28, 2003 01:58 UTC | AAIPHARMA INC AAII · Entity 14033 | SaleCommon Stock | 5,000 | $17.56 | $87,800.00 |
DisclosureSEC source: 0000769993-03-000591 · aaii4031023gsg_ex.xml · nonDerivative · entry 2 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 · CIK 0000941168 · 10% owner GOLDMAN SACHS & CO OHG · CIK 0001031766 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,415,247 F1 · balance_after: The positions reported herein have been adjusted to reflect aaiPharma, Inc.'s (the "Company") February 19, 2003 three-for-two common stock split. F1 · ownership.nature: The positions reported herein have been adjusted to reflect aaiPharma, Inc.'s (the "Company") February 19, 2003 three-for-two common stock split. F2 · ownership.nature: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Advisors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs), and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F3 · ownership.nature: The securities reported herein as purchased and sold were purchased and sold and were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to the Company. The Reporting Persons other than GS Group and Goldman Sachs disclaim beneficial ownership of the shares of Common Stock beneficially owned directly by Goldman Sachs. F4 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein. F5 · ownership.nature: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F6 · ownership.nature: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. Read SEC document |
| October 23, 2003 Filed Oct 28, 2003 01:58 UTC | AAIPHARMA INC AAII · Entity 14033 | PurchaseCommon Stock | 5,000 | $17.56 | $87,800.00 |
DisclosureSEC source: 0000769993-03-000591 · aaii4031023gsg_ex.xml · nonDerivative · entry 1 GOLDMAN SACHS GROUP INC/ · CIK 0000886982 · 10% owner GOLDMAN SACHS & CO · CIK 0000769993 · 10% owner GS CAPITAL PARTNERS II L P · CIK 0000945125 · 10% owner GS CAPITAL PARTNERS II OFFSHORE LP · CIK 0001031770 · 10% owner GS CAPITAL PARTNERS II GERMANY CLP · CIK 0001035098 · 10% owner BRIDGE STREET FUND 1995 LP · CIK 0000941186 · 10% owner STONE STREET FUND 1995 · CIK 0000941168 · 10% owner GOLDMAN SACHS & CO OHG · CIK 0001031766 · 10% owner GS ADVISORS II LLC · CIK 0001232082 · 10% owner GS ADVISORS LLC · CIK 0001232084 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: Not disclosed Ownership: Indirect · See Footnotes Disclosed balance after: 3,420,247 F1 · balance_after: The positions reported herein have been adjusted to reflect aaiPharma, Inc.'s (the "Company") February 19, 2003 three-for-two common stock split. F1 · ownership.nature: The positions reported herein have been adjusted to reflect aaiPharma, Inc.'s (the "Company") February 19, 2003 three-for-two common stock split. F2 · ownership.nature: This statement is being filed by GS Capital Partners II, L.P. (GSCP), GS Capital Partners II Offshore, L.P. (GSCP II Offshore), GS Capital Partners II (Germany) Civil Law Partnership (GSCP II Germany), Stone Street Fund 1995, L.P. (1995 Stone) and Bridge Street Fund 1995, L.P. ("1995 Bridge" and, together with GSCP, GSCP II Offshore, GSCP II Germany and 1995 Stone, the "Limited Partnerships"), Stone Street 1995, L.L.C. (Stone GP), GS Advisors, L.L.C. (GS Advisors), GS Advisors II, L.L.C. (GS Advisors II), Goldman, Sachs & Co. oHG (GS oHG), Goldman, Sachs & Co. (Goldman Sachs), and The Goldman Sachs Group, Inc. ("GS Group" and, together with Goldman Sachs, GS Advisors, GS Advisors II, GS oHG, Stone GP and the Limited Partnerships, the "Reporting Persons"). Due to the electronic system's limitation of 10 Reporting Persons per joint filing, this statement is being filed in duplicate. F3 · ownership.nature: The securities reported herein as purchased and sold were purchased and sold and were beneficially owned directly by Goldman Sachs. Without admitting any legal obligation, Goldman Sachs will remit appropriate profits, if any, to the Company. The Reporting Persons other than GS Group and Goldman Sachs disclaim beneficial ownership of the shares of Common Stock beneficially owned directly by Goldman Sachs. F4 · ownership.nature: Goldman Sachs and GS Group may be deemed to beneficially own indirectly in the aggregate 3,415,247 shares of Common Stock through the Limited Partnerships, of which affiliates of Goldman Sachs and GS Group are the general partner, managing general partner or managing partner. Goldman Sachs is an indirect wholly-owned subsidiary of GS Group. Goldman Sachs is the investment manager of GSCP, GSCP II Offshore, and GSCP II Germany. Goldman Sachs and GS Group each disclaims beneficial ownership of the shares of Common Stock owned by the Limited Partnerships except to the extent of their pecuniary interest therein. F5 · ownership.nature: GSCP beneficially owns directly and its general partner, GS Advisors, may be deemed to beneficially own indirectly 2,142,823 shares of Common Stock. GSCP II Offshore beneficially owns directly and its general partner, GS Advisors II, may be deemed to beneficially own indirectly 851,862 shares of Common Stock. GSCP II Germany beneficially owns directly and its managing partner, GS oHG, may be deemed to beneficially own indirectly 79,036 shares of Common Stock. 1995 Stone beneficially owns directly and its general partner, Stone GP, may be deemed to beneficially own indirectly 160,698 shares of Common Stock through 1995 Stone. 1995 Bridge beneficially owns directly and its managing general partner, Stone GP, may be deemed to beneficially own indirectly 180,828 shares of Common Stock through 1995 Bridge. F6 · ownership.nature: Each of GS Advisors, GS Advisors II, GS oHG and Stone GP disclaims beneficial ownership of the securities reported herein except to the extent of its pecuniary interest in such securities. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.